The	O
role	O
of	O
platelet	O
-	O
derived	O
endothelial	O
cell	O
growth	O
factor	O
/	O
thymidine	O
phosphorylase	O
in	O
tumor	B-Cancer
behavior	O
.	O

Platelet	O
-	O
derived	O
endothelial	O
cell	O
growth	O
-	O
factor	O
(	O
PD	O
-	O
ECGF	O
)	O
is	O
similar	O
to	O
the	O
pyrimidine	O
enzyme	O
thymidine	O
phosphorylase	O
(	O
TP	O
)	O
.	O

A	O
high	O
TP	O
expression	O
at	O
tumor	B-Cancer
sites	I-Cancer
is	O
correlated	O
with	O
tumor	B-Cancer
growth	O
,	O
induction	O
of	O
angiogenesis	O
,	O
and	O
metastasis	O
.	O

Therefore	O
,	O
high	O
TP	O
is	O
most	O
likely	O
associated	O
with	O
a	O
poor	O
prognosis	O
.	O

TP	O
is	O
not	O
only	O
expressed	O
in	O
tumor	B-Cell
cells	I-Cell
but	O
also	O
in	O
tumor	B-Tissue
surrounding	I-Tissue
tissues	I-Tissue
,	O
such	O
as	O
tumor	B-Cell
infiltrating	I-Cell
macrophages	I-Cell
.	O

TP	O
catalyzes	O
the	O
conversion	O
of	O
thymidine	O
to	O
thymine	O
and	O
doxyribose	O
-	O
1	O
-	O
phosphate	O
(	O
dR	O
-	O
1	O
-	O
P	O
)	O
.	O

The	O
latter	O
in	O
its	O
parent	O
form	O
or	O
in	O
its	O
sugar	O
form	O
,	O
deoxyribose	O
(	O
dR	O
)	O
may	O
play	O
a	O
role	O
in	O
the	O
induction	O
of	O
angiogenesis	O
.	O

It	O
may	O
modulate	O
cellular	B-Cell
energy	O
metabolism	O
or	O
be	O
a	O
substrate	O
in	O
a	O
chemical	O
reaction	O
generating	O
reactive	O
oxygen	O
species	O
.	O

L	O
-	O
deoxyribose	O
(	O
L	O
-	O
dR	O
)	O
and	O
thymidine	O
phosphorylase	O
inhibitor	O
(	O
TPI	O
)	O
can	O
reverse	O
these	O
effects	O
.	O

The	O
mechanism	O
of	O
TP	O
induction	O
is	O
not	O
yet	O
completely	O
clear	O
,	O
but	O
TNF	O
,	O
IL10	O
and	O
other	O
cytokines	O
have	O
been	O
clearly	O
shown	O
to	O
induce	O
its	O
expression	O
.	O

The	O
various	O
complex	O
interactions	O
of	O
TP	O
give	O
it	O
an	O
essential	O
role	O
in	O
cellular	B-Cell
functioning	O
and	O
,	O
hence	O
,	O
it	O
is	O
an	O
ideal	O
target	O
in	O
cancer	B-Cancer
therapy	O
.	O

